The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
ASTP Conference offers great networking and learning opportunities; a chance to share knowledge with colleagues from various areas of expertise.
Bruno Woeran
Merinova OY - TII President, Finland
ASTP brought the right structure and terminology to my knowledge of technology licensing.
René Widmer
ETH Transfer, Switzerland
I really like the course and the networking. I would like to come again.
Nancy Goel
Qatar Foundation, Qatar
As always, superb topics and inspirational speakers. Great networking. Well worth the time out of the office!!! Great work HQ, thank you.
Peter Deakin
Chalmers University of Technology, Sweden
I learned more in the training course for 3 days than I did in the last 3 months at my job. The lectures were informative & interesting.
Hanna Sonnig
Setterwalls Advokatbyrå, Sweden
Join our newsletter and get the latest news